New on this website

20.12.2024

Out-of-Stock – Vaborem Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Befristete Bewilligung zum Vertrieb in italienischer Aufmachung

20.12.2024

Summary report on authorisation – Sarclisa®

Extension of therapeutic indication (01)

20.12.2024

Summary report on authorisation – Lytgobi®

First authorisation

20.12.2024

Updated information on BIA-ALCL

Reports on breast-implant associated-anaplastic large cell lymphoma (BIA-ALCL) in Switzerland 2012–2024

20.12.2024

Swissmedic podcast #4: Clinical Trials - basis for high-quality medications

Alex Josty interviews Simone Ferbitz-Scheurer, Head of the Clinical trials Division

19.12.2024

HPC – Medicines containing betahistine

Important safety-related information

18.12.2024

Successful operation in control campaign against illegal trading in medicinal products

Swissmedic, the Federal Office for Customs and Border Security (FOCBS) and Swiss Sport Integrity (SSI) confiscated one quarter of more than 1,000 consignments checked

18.12.2024

Quality Assessor (80-100%)

Job advertisement | Abteilung Quality Assessment (Einheit Synthetika)

16.12.2024

Batch recall – Vitamin B6 Streuli 40 mg Tabletten

Rückzug der Chargen 2300264AA, 2300265AA und 2300265AB bis auf Stufe Detailhandel

16.12.2024

HPC – Systemisch und inhalativ angewendete Fluorchinolonantibiotika

Erinnerung an Anwendungseinschränkungen aufgrund des Sicherheitsprofils

16.12.2024

Swissmedic: Vital hub in the joint campaign to combat therapeutic products crime

Five years as national single point of contact (SPOC) for Medicrime Convention

16.12.2024

Summary report on authorisation – Skyclarys®

First authorisation
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page

Last modification 12.12.2024

Top of page